This company has been marked as potentially delisted and may not be actively trading. Amedica (AMDA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock AMDA vs. LUCD, KRMD, INFU, OBIO, LUNG, ICAD, GUTS, MBOT, MGRM, and SRTSShould you be buying Amedica stock or one of its competitors? The main competitors of Amedica include Lucid Diagnostics (LUCD), KORU Medical Systems (KRMD), InfuSystem (INFU), Orchestra BioMed (OBIO), Pulmonx (LUNG), iCAD (ICAD), Fractyl Health (GUTS), Microbot Medical (MBOT), Monogram Orthopaedics (MGRM), and Sensus Healthcare (SRTS). Amedica vs. Its Competitors Lucid Diagnostics KORU Medical Systems InfuSystem Orchestra BioMed Pulmonx iCAD Fractyl Health Microbot Medical Monogram Orthopaedics Sensus Healthcare Amedica (NASDAQ:AMDA) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, dividends, risk, profitability, analyst recommendations, media sentiment and institutional ownership. Does the media refer more to AMDA or LUCD? In the previous week, Lucid Diagnostics had 3 more articles in the media than Amedica. MarketBeat recorded 3 mentions for Lucid Diagnostics and 0 mentions for Amedica. Lucid Diagnostics' average media sentiment score of 1.11 beat Amedica's score of 0.00 indicating that Lucid Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment Amedica Neutral Lucid Diagnostics Positive Which has higher valuation & earnings, AMDA or LUCD? Amedica has higher revenue and earnings than Lucid Diagnostics. Amedica is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmedica$11.23M3.26-$9.32M-$3.13-0.98Lucid Diagnostics$4.17M33.44-$52.67M-$1.34-0.96 Does the MarketBeat Community believe in AMDA or LUCD? Amedica received 264 more outperform votes than Lucid Diagnostics when rated by MarketBeat users. However, 69.35% of users gave Lucid Diagnostics an outperform vote while only 64.90% of users gave Amedica an outperform vote. CompanyUnderperformOutperformAmedicaOutperform Votes30764.90% Underperform Votes16635.10% Lucid DiagnosticsOutperform Votes4369.35% Underperform Votes1930.65% Do institutionals & insiders have more ownership in AMDA or LUCD? 3.7% of Amedica shares are owned by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are owned by institutional investors. 0.9% of Amedica shares are owned by insiders. Comparatively, 6.8% of Lucid Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more volatility & risk, AMDA or LUCD? Amedica has a beta of -1.24, suggesting that its stock price is 224% less volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.31, suggesting that its stock price is 31% more volatile than the S&P 500. Do analysts rate AMDA or LUCD? Lucid Diagnostics has a consensus price target of $3.55, indicating a potential upside of 175.19%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe Lucid Diagnostics is more favorable than Amedica.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Amedica 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Is AMDA or LUCD more profitable? Amedica has a net margin of -139.62% compared to Lucid Diagnostics' net margin of -1,069.87%. Lucid Diagnostics' return on equity of 0.00% beat Amedica's return on equity.Company Net Margins Return on Equity Return on Assets Amedica-139.62% -148.60% -67.83% Lucid Diagnostics -1,069.87%N/A -123.54% SummaryLucid Diagnostics beats Amedica on 13 of the 19 factors compared between the two stocks. Get Amedica News Delivered to You Automatically Sign up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AMDA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AMDA vs. The Competition Export to ExcelMetricAmedicaSurgical & Medical Instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$36.56M$4.32B$5.58B$8.49BDividend YieldN/A42.67%5.28%4.17%P/E Ratio-0.9827.8027.1819.64Price / Sales3.2668.36408.37152.20Price / CashN/A51.0838.3234.64Price / Book1.715.746.974.60Net Income-$9.32M$66.95M$3.23B$248.06M Amedica Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AMDAAmedicaN/A$3.08+6.5%N/A-37.1%$36.56M$11.23M-0.98N/AGap DownLUCDLucid Diagnostics3.5425 of 5 stars$1.23+0.4%$3.50+185.7%+74.9%$131.45M$4.17M-1.0770Positive NewsShort Interest ↓KRMDKORU Medical Systems3.3309 of 5 stars$2.82-0.1%$4.50+59.8%+36.2%$130.35M$35.08M-11.3080INFUInfuSystem2.397 of 5 stars$6.07-0.5%$13.00+114.2%N/A$127.57M$137.58M101.18410News CoverageNegative NewsShort Interest ↑OBIOOrchestra BioMed3.0771 of 5 stars$3.25-0.3%$14.20+336.9%-60.2%$124.52M$2.89M-2.024Positive NewsLUNGPulmonx3.8424 of 5 stars$3.06-0.6%$11.53+276.6%-53.8%$122.63M$87.47M-2.12250Positive NewsICADiCAD1.0307 of 5 stars$3.85+2.1%N/A+144.2%$105.49M$19.53M-29.54140News CoverageShort Interest ↓GUTSFractyl Health2.3761 of 5 stars$2.00+1.3%$11.00+451.4%-64.4%$97.71M$60K-0.16102News CoverageMBOTMicrobot Medical1.9545 of 5 stars$2.68-3.1%$9.00+236.4%+127.5%$97.13MN/A-3.3420News CoverageAnalyst RevisionMGRMMonogram Orthopaedics2.9328 of 5 stars$2.48+1.4%$5.40+118.2%+24.6%$89.01M$365.00K-5.3128Positive NewsSRTSSensus Healthcare2.4773 of 5 stars$5.11+4.5%$11.67+128.3%-8.8%$83.71M$39.49M12.7340Positive News Related Companies and Tools Related Companies Lucid Diagnostics Competitors KORU Medical Systems Competitors InfuSystem Competitors Orchestra BioMed Competitors Pulmonx Competitors iCAD Competitors Fractyl Health Competitors Microbot Medical Competitors Monogram Orthopaedics Competitors Sensus Healthcare Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AMDA) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AMDA Stock Free AMDA Stock Alerts